The proteolytic activity of insulin-degrading enzyme: A mass spectrometry study

Journal of Mass Spectrometry

Volumn 44, Issue 5, 2009, Pages 735-741

  Grasso, Giuseppe ^a   Rizzarelli, Enrico ^a,b   Spoto, Giuseppe ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b CNR   (Italy)

Author keywords

ATP; IDE; Insulin; MALDI; Mass spectrometry; Metal; Oligomer

Indexed keywords

AMYLOIDOGENIC PEPTIDES; ATP; CLEAVAGE PATTERNS; CLEAVAGE SITES; CONCENTRATION RATIO; DESORPTION IONIZATION; ENVIRONMENTAL FACTORS; IDE; INSULIN-DEGRADING ENZYMES; MALDI; PROTEOLYTIC ACTIVITIES; REACTION TIME; TRIPHOSPHATE;

AMINES; ATMOSPHERIC IONIZATION; DEGRADATION; DESORPTION; ENZYME ACTIVITY; ENZYMES; INSULIN; MASS SPECTROMETERS; MASS SPECTROMETRY; METAL IONS; SPECTRUM ANALYSIS; ZINC;

INTEGRODIFFERENTIAL EQUATIONS;

ADENOSINE TRIPHOSPHATE; COPPER; INSULINASE; ZINC;

ARTICLE; ATMOSPHERIC PRESSURE; CONCENTRATION (PARAMETERS); ENVIRONMENTAL FACTOR; ENZYME ACTIVE SITE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN MODIFICATION; QUALITATIVE ANALYSIS; REACTION TIME;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; INSULIN; INSULYSIN; MOLECULAR SEQUENCE DATA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

EID: 66249126847     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1550     Document Type: Article

References (29)

1. [1] W. Farris, S. Mansourian, Y.Chang, L.Lindsley, E. A. Eckman, M.P.Frosch, C.B. Eckman, R. E.Tanzi, D.J. Selkoe, S.Guénette. Insulin-degrading enzyme regulates the levels of insulin, amyloid β- protein, and the β-amyloid precursor protein intracellular domain in vivo. Proceedings of the National Academy of Sciences of the United States of America 2003, 100,4162.
2. I. V. Kurochkin. Insulin-degrading enzyme: embarking on amyloid destruction. Trends in Biochemical Sciences 2001, 26, 421.
3. M. E.-L. Blomqvist, P.A. Silburn, D.D.Buchanan, N.Andreasen, K. Blennow, N. L. Pedersen, A. J. Brookes, G. D. Mellick, J. A. Prince. Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease. Neurogenetics 2004, 5, 115.
4. D. G. Cook, J. B. Leverenz, P. J. McMillan, J. J. Kulstad, S. Ericksen, R. A. Roth, G. D. Schellenberg, L. W. Jin, K. S. Kovacina, S. Craft. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. American Journal of Pathology 2003, 162, 313.
5. M. Kim, L. B. Hersh, M. A. Leissring, M. Ingelsson,T. Matsui, W. Farris, A. Lu, B.T. Hyman, D.J.Selkoe, L. Bertram, R. E. Tanzi. Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families. Journal of Biological Chemistry 2007, 282, 7825.
6. Y. Shen,A. Joachimiak, M. R. Rosner, W.-J. Tang. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 2006, 443, 870.
7. P.Li, W.-L.Kuo, M.Yousef, M. R. Rosner, W.-J. Tang. The C-terminal domain of human insulin degrading enzyme is required for dimerization and substrate recognition. Biochemical and Biophysical Research Communications 2006, 343, 1032.
8. E.S.Song, A. Daily, M. G.Fried, M. A.Juliano, L. Juliano, L.B. Hersh. Mutation of active site residues of insulin-degrading enzyme alters allosteric interactions. Journal of Biological Chemistry 2005, 280, 17701.
9. E. S. Song, M. A. Juliano, L. Juliano, L. B. Hersh. Substrate activation of insulin degrading enzyme (insulysin), A potential target for drug development. Journal of Biological Chemistry 2003, 278, 49789.
10. J. S. Miners, P. G. Kehoe, S. Love. Immunocapture-based fluoromet- ric assay for the measurement of insulin-degrading enzyme activity in brain tissue homogenates. Journal of Neuroscience Methods 2008, 169, 177.
11. M. C. Camberos, A. A.Perez, D. P.Udrisar, M. I. Wanderley, J. C. Cresto. ATP inhibits insulin-degrading enzyme activity. Experimental Biology and Medicine 2001, 226, 334.
12. J. A. Affholter, M. A. Cascieri, M. L. Bayne, J. Brange, M. Casaretto, R. A. Roth. Identification of residues in the insulin molecule important for binding to insulin-degrading enzyme. Biochemistry 1990, 29, 7727.
13. J. L. Diaz, T. J. Wilkin. Effect of iodination site on binding of radiolabeled ligand by insulin antibodies and insulin autoantibodies. ClinicalChemistry1988, 34, 356.
14. G. Grasso, E. Rizzarelli, G. Spoto. How the binding and degrading capabilities of insulin degrading enzyme are affected by ubiquitin. Biochimica et Biophysica Acta 2008, 1784, 1122.
15. G.Grasso, E. Rizzarelli, G.Spoto. AP-MALDI/MS complete characterization of insulin fragments produced by the interaction of IDE with bovine insulin. Journal of Mass Spectrometry 2007, 42, 1590.
16. E. S. Song, M. A. Juliano, L. Juliano, M. G. Fried, S. L. Wagner, L. B. Hersh. ATP effects on insulin-degrading enzyme are mediated primarily through its triphosphate moiety. Journal of Biological Chemistry2004, 279, 54216.
17. A. Ebrahim, F. G. Hamel, R. G. Bennett, W. C. Duckworth. Identification of the metal associated with the insulin degrading enzyme. Biochemical and Biophysical Research Communications 1991, 181, 1398.
18. W. C. Duckworth. Insulin degradation: mechanisms, products, and significance. Endocrine Reviews 1988, 9, 319.
19. P. V. Tan, V. V. Laiko, V. M. Doroshenko. Atmospheric pressure MALDI with pulsed dynamic focusing for high-efficiency transmission of ions into a mass spectrometer. Analytical Chemistry 2004, 76, 2462.
20. B. B. Schneider, C. Lock, T. R. Covey. AP and vacuum MALDI on a QqLIT instrument. Journal of the American Society for Mass Spectrometry 2005, 16, 176.
21. 17-30 produced by insulin proteinase. Rapid Communicationsin MassSpectrometry 1993, 7, 1048.
22. A. Safavi, B.C. Miller, L. Cottam, L. B. Hersh. Identification of γ - endorphin-generating enzyme as insulin-degrading enzyme. Biochemistry1996, 35, 14318.
23. H. Im, M. Manolopoulou, E. Malito, Y. Shen, J. Zhao, M. Neant-Fery, C.-Y. Sun, S. C. Meredith, S. S. Sisodia, M. A. Leissring, W.-J. Tang. Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE. Journal of Biological Chemistry 2007, 282, 25453.
24. D. Sarracino, C. Richert. Quantitative MALDI-TOF MS of oligonucleotides and a nuclease assay. Bioorganic & Medicinal Chemistry Letters 1996, 6, 2543.
25. A. Shevchenko. Evaluation of the efficiency of in-gel digestion of proteins by peptide isotopic labeling and MALDI mass spectrometry. Analytical Biochemistry 2001, 296, 279.
26. A. I. Bush, C. C. Curtain. Twenty years of metallo-neurobiology: where to now? European Biophysics Journal 2008, 37, 241.
27. F. G. Hamel, R. Bennett, W. C. Duckworth. Regulation of multicatalytic enzyme activity by insulin and the insulin-degrading enzyme. Endocrinology 1998, 139, 4061.
28. F. D. Coffman, M.F.Dunn. Insulin-metal ion interactions: the binding of divalent cations to insulin hexamers and tetramers and the assembly of insulin hexamers. Biochemistry 1988, 27, 6179.
29. J. Hudecek, P. Anzenbacher, V. Kalous. Interaction of insulin with metal(II) ions. FEBS Letters 1979, 100, 374.